Navigation Links
La Jolla Institute scientist Klaus Ley receives Malpighi award
Date:10/25/2010

SAN DIEGO (October 25, 2010) Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.

Mitchell Kronenberg, Ph.D., La Jolla Institute president & chief scientific officer, said the award comes as no surprise. "Dr. Ley is undeniably one of the top researchers in the world in vascular immunology," he said. "His contributions to better understanding of inflammation's critical role in heart disease have been vast and have led to new diagnostics and potential treatments for arterial diseases."

In announcing the award, the European Society for Microcirculation noted that it "honors researchers who are active in the field and stand out through their publications and scientific contributions, service to the entire field of microcirculatory and vascular biology research, and by their promotion of younger scientists." Dr. Ley was also asked to present the Malpighi lecture during the World Congress as part of the award.

Dr. Ley, who heads the La Jolla Institute's Division of Inflammation Biology, said he was honored to receive the Malpighi award. "It was really exciting to join this group of 17 highly respected scientists."

Dr. Ley's most significant discoveries over the years, related to heart disease, were in three major scientific areas: molecular mechanisms, biomechanics and methods development. In molecular mechanisms, Dr. Ley was one of the early discoverers of the "leukocyte adhesion cascade," a sequence of molecular ev
'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. La Jolla Institute scientist leads team which discovers important new player in diabetes onset
2. Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
3. La Jolla Institute discovers novel tumor suppressor
4. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
5. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
6. The AACR congratulates its members elected to the Institute of Medicine
7. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
8. Virtual research institute needed to unlock RNAs promise
9. Salk Institute Medals to be awarded to Robert Roeder and Irwin Jacobs
10. Brown Institute for Brain Science marks decade of research impact
11. Cardiovascular Innovation Institute researchers receive over $2 million grant from NIH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Cryoport, Inc. (OTCBB: ... cryogenic logistics solutions for the life sciences ... cell lines, clinical research organizations, vaccine manufacturers, ... the expansion of its relationship with ... Hutch") Clinical Research Division with the inclusion ...
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2
... Washington, D.C. (September 14, 2010) -- Because one ... protein molecules is producing good isolated single crystals, improved ... of genomics and pharmaceutical research. Research reported ... fluorescence correlation spectroscopy (FCS) to investigate the processes at ...
... Biological Sciences Research Council,(BBSRC) have discovered key plant enzymes that ... non-edible parts of plants difficult to extract. The findings, published ... , can be used to improve the viability of sustainable ... The team based at the University of Cambridge, and now ...
... genetic study to compare nuclear DNA of endangered Antillean ... as separate subspecies. Belize,s manatees, however, were found to ... long-term genetic viability. The Central American country of ... manatees and is touted by biologists for its potential ...
Cached Biology News:How do your crystals grow? 2Biofuel from inedible plant material easier to produce following enzyme discovery 2Manatee subspecies genetically confirmed, but diversity challenge looms 2Manatee subspecies genetically confirmed, but diversity challenge looms 3
(Date:3/5/2015)... Chardon, Ohio (PRWEB) March 05, 2015 ... and Gold Development Partner located in Northeast Ohio, today ... chosen e2b teknologies to support its upgrade to the ... As the largest independent group practice of its kind ... base and large volume of transactions, so efficiency and ...
(Date:3/4/2015)... VILLAGE, Nev. , March 4, 2015 PDL BioPharma, ... the adjusted conversion rate for the: , 3.75% ... is 174.8506 shares of common stock per $1,000 principal amount ... The conversion rate for the note is adjusted in ... paid on March 12, 2015, to all stockholders who own shares ...
(Date:3/4/2015)... , March 4, 2015  Brooklyn residents now have ... and chronic pain and injuries. Nunzio Saulle , ... grand opening of his NJS Physical Medicine and Rehabilitation ... on Thursday, March 5, 2015. Health Plus Management, LLC ... is located at 1178 Flatbush Avenue. This new PM&R ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biologics and Biosimilars Industry Report ... The Global Biologics and Biosimilars Industry ... on the current state of the biologics and ... basic overview of the industry including definitions, classifications, ...
Breaking Biology Technology:Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2Global Biologics and Biosimilars Industry Report 2015-2020 2
... (Nasdaq: NBIX ) announced today that Kevin Gorman, ... Chief Executive,Officer and a member of the Board of ... President and Chief Executive Officer of,Neurocrine and will continue ... "While this was a very difficult decision for ...
... 14 VIRxSYS Corporation, a,privately held company developing ... Corporation, a privately-owned biotechnology company,focused on the manufacture ... have agreed to settle the pending litigation between,the ... and counterclaims,asserted in the lawsuit, which has been ...
... Patients are ... in the U.S., REHOVOT, Israel and NORTH BRUNSWICK, ... ROSG ), a leader,in the development of microRNA-based diagnostics ... with the Henry Ford,Health System in Detroit, Michigan, to ...
Cached Biology Technology:Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer 2VIRxSYS and Lentigen Announce Litigation Settlement 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 4
... Perhaps sheer in-house demand is causing shortages in ... antibody. This can cause unwanted distractions, problems and ... for your hard work and endeavour! Bring us ... and market it internationally. We work under ISO ...
... Diluted Antiserum for RIA, Host: Rabbit ... Immunology Products, Host: Rabbit Antigen ... peptide and 1 2 ... (rat) (H-9295) and ([ 1 2 ...
... vaccinia virus is a type I eukaryotic ... superhelical turns (also called right- and left-handed ... of the reaction is a covalently closed, ... superhelical turns. DNA Topoisomerase I does not ...
...
Biology Products: